The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn FDA Grants Accelerated Approval to Ipilimumab for Certain Metastatic Colorectal Cancers Oncology Nursing Society Doctor Explains The FDA Approved Peptide for BURNING Belly Fat (Tesamorelin Peptide)